These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1502480)

  • 21. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
    Nyrén O; Adami HO; Bates S; Bergström R; Gustavsson S; Lööf L; Nyberg A
    N Engl J Med; 1986 Feb; 314(6):339-43. PubMed ID: 3511376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence.
    Danielsson A; Ek B; Steen L
    Eur J Clin Pharmacol; 1981; 19(5):335-41. PubMed ID: 6786895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance treatment of recurrent peptic ulcer by cimetidine.
    Bodemar G; Walan A
    Lancet; 1978 Feb; 1(8061):403-7. PubMed ID: 75439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study.
    Farup PG; Weberg R; Berstad A; Wetterhus S; Dahlberg O; Dybdahl J; Fyllingen G; Kannelønning KS; Lange OJ
    Scand J Gastroenterol; 1990 Mar; 25(3):315-20. PubMed ID: 2181623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cimetidine in non-ulcer dyspepsia. Preliminary results with a multi-crossover model].
    Løge I; Johannesen T; Hafstad PE; Kristensen P; Sandbakken P; Pettersen H; Kleveland PM; Fjøsne U; Larsen S; Sandvik L
    Tidsskr Nor Laegeforen; 1985 Aug; 105(23):1491-3. PubMed ID: 3901394
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cimetidine in symptomatic gastro-oesophageal reflux.
    Powell-Jackson P; Barkley H; Northfield TC
    Lancet; 1978 Nov; 2(8099):1068-9. PubMed ID: 82086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled trial of cimetidine in reflux esophagitis.
    Fiasse R; Hanin C; Lepot A; Descamps C; Lamy F; Dive C
    Dig Dis Sci; 1980 Oct; 25(10):750-5. PubMed ID: 7000475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intensity and variability of symptoms in dyspepsia.
    Johannessen T; Petersen H; Kristensen P; Kleveland PM; Dybdahl J; Sandvik AK; Brenna E; Waldum H
    Scand J Prim Health Care; 1993 Mar; 11(1):50-5. PubMed ID: 8484080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological interventions for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
    Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy.
    Collen MJ; Hanan MR; Maher JA; Rent M; Stubrin SE; Arguello JF; Gardner L
    Dig Dis Sci; 1980 Oct; 25(10):744-9. PubMed ID: 7000474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.
    Halter F; Miazza B; Brignoli R
    Scand J Gastroenterol; 1994 Jul; 29(7):618-23. PubMed ID: 7939398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic effect of cimetidine in gastric ulcer patients.
    Jensen KB; Møllmann KM; Rahbek I; Madsen JR; Rune SJ; Wulff HR
    Scand J Gastroenterol; 1979; 14(2):175-6. PubMed ID: 373071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
    Breen KJ; Desmond PV; Whelan G
    Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study.
    Gudjónsson H; Oddsson E; Björnsson S; Gunnlaugsson O; Theodors A; Jónasson TA; Bonnevie O; Thjodleifsson B
    Scand J Gastroenterol; 1993 Nov; 28(11):969-72. PubMed ID: 8284632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for non-ulcer dyspepsia.
    Soo S; Moayyedi P; Deeks J; Delaney B; Innes M; Forman D
    Cochrane Database Syst Rev; 2000; (2):CD001960. PubMed ID: 10796840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with a multi crossover model in dyspepsia.
    Johannessen T; Fosstvedt D; Petersen H
    Scand J Gastroenterol Suppl; 1988; 147():33-7. PubMed ID: 3201142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.
    Babu V; Kate V; Ananthakrishnan N
    Trop Gastroenterol; 2005; 26(4):211-4. PubMed ID: 16737055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis.
    Schotborgh RH; Hameeteman W; Dekker W; vd Boomgaard DM; Van Olffen GH; Schrijver M; Vosmaer GD; Tytgat GN
    Am J Med; 1989 Jun; 86(6A):77-80. PubMed ID: 2660561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of reflux oesophagitis with cimetidine (author's transl)].
    Lepsien G; Sonnenberg A; Berges W; Weber KB; Wienbeck M; Siewert JR; Blum AL
    Dtsch Med Wochenschr; 1979 Jun; 104(25):901-6. PubMed ID: 446319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.